Blueprint Medicines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BPMC and buy or sell other stocks, ETFs, and their options commission-free!About BPMC
Blueprint Medicines Corp. is a precision therapy company, which engages in the provision of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B.
CEOKathryn Haviland, MBA
CEOKathryn Haviland, MBA
Employees649
Employees649
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2008
Founded2008
Employees649
Employees649
BPMC Key Statistics
Market cap8.36B
Market cap8.36B
Price-Earnings ratio-52.60
Price-Earnings ratio-52.60
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$129.65
52 Week high$129.65
52 Week low$73.04
52 Week low$73.04
Stock Snapshot
Blueprint Medicines(BPMC) stock is priced at $129.46, giving the company a market capitalization of 8.36B. It carries a P/E multiple of -52.60.
During the trading day, Blueprint Medicines(BPMC) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Blueprint Medicines(BPMC) stock has reached 0.
Over the past 52 weeks, Blueprint Medicines(BPMC) stock has traded between a high of $129.65 and a low of $73.04.
Over the past 52 weeks, Blueprint Medicines(BPMC) stock has traded between a high of $129.65 and a low of $73.04.
People also own
Based on the portfolios of people who own BPMC. This list is generated using Robinhood data, and it’s not a recommendation.